Advanced non-small cell non-squamous lung cancer

Clinical trials for Advanced non-small cell non-squamous lung cancer explained in plain language.

Never miss a new study

Get alerted when new Advanced non-small cell non-squamous lung cancer trials appear

Sign up with your email to follow new studies for Advanced non-small cell non-squamous lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Lung cancer drug trial halted early: what we know

Disease control Stopped early

This early-stage trial tested a new drug called MYTX-011 for people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a powerful chemotherapy directly to cancer cells…

Matched conditions: ADVANCED NON-SMALL CELL NON-SQUAMOUS LUNG CANCER

Phase 1 • Sponsor: Mythic Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC

Advanced non-small cell non-squamous lung cancer

Get alerted when new Advanced non-small cell non-squamous lung cancer trials appear

Lung cancer drug trial halted early: what we know